Noncoding RNAs and myocardial fibrosis
暂无分享,去创建一个
[1] 李永军,et al. Atrial Fibrillation , 1999 .
[2] A. Haverich,et al. Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] M. Jessup,et al. Heart failure. , 2003, The New England journal of medicine.
[4] Paul Martin,et al. Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice , 2004, Genome Biology.
[5] Xiaoxia Qi,et al. Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.
[6] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[7] Juan Pablo Couso,et al. Peptides Encoded by Short ORFs Control Development and Define a New Eukaryotic Gene Family , 2007, PLoS biology.
[8] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[9] Y. Pinto,et al. Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling , 2008, Circulation.
[10] W. Rottbauer,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.
[11] Jeffrey E. Thatcher,et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.
[12] G. Nuovo,et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.
[13] R. Duisters,et al. MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .
[14] Ning Wang,et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. , 2009, Cardiovascular research.
[15] R. Goldschmeding,et al. Connective tissue growth factor and cardiac fibrosis , 2009, Acta physiologica.
[16] S. Kauppinen,et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.
[17] Michael S. Ewer,et al. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know , 2010, Nature Reviews Cardiology.
[18] J. Nerbonne,et al. MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts , 2010, Circulation research.
[19] Takeshi Kimura,et al. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway , 2010, Cardiovascular research.
[20] T. Thum,et al. Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.
[21] G. Condorelli,et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling , 2010, Nature Cell Biology.
[22] N. Kaminski,et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis , 2010 .
[23] M. Vinciguerra,et al. MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation , 2011, Circulation research.
[24] P. Fawcett,et al. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. , 2011, American journal of respiratory cell and molecular biology.
[25] G. Angelini,et al. Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132 , 2011, Circulation research.
[26] P. Linsley,et al. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. , 2011, The Journal of clinical investigation.
[27] J. Bauersachs,et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. , 2011, Journal of molecular and cellular cardiology.
[28] B. Schroen,et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure , 2011, Aging cell.
[29] D. Bernstein,et al. Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. , 2012, Physiological genomics.
[30] Haifeng Jin,et al. Let-7 g is involved in doxorubicin induced myocardial injury. , 2012, Environmental toxicology and pharmacology.
[31] S. Kauppinen,et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function , 2012, Proceedings of the National Academy of Sciences.
[32] Yanjie Lu,et al. A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. , 2012, The international journal of biochemistry & cell biology.
[33] Stephane Heymans,et al. MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis , 2012, Circulation research.
[34] Aaron N. Chang,et al. MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways , 2012, Science Translational Medicine.
[35] Xiaoxia Qi,et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.
[36] T. Moccetti,et al. Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation , 2012, Journal of transplantation.
[37] S. Themistoclakis,et al. Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. , 2012, Heart rhythm.
[38] T. Thum. MicroRNA therapeutics in cardiovascular medicine , 2012, EMBO molecular medicine.
[39] Achilleas S. Frangakis,et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.
[40] E. Finch,et al. MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes , 2012, Circulation research.
[41] A. Ghosh,et al. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. , 2012, Cellular signalling.
[42] E. Olson,et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. , 2012, The Journal of clinical investigation.
[43] U. Laufs,et al. Role of miR-21 in the pathogenesis of atrial fibrosis , 2012, Basic Research in Cardiology.
[44] Nadav S. Bar,et al. Landscape of transcription in human cells , 2012, Nature.
[45] David Milan,et al. Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5 , 2012, Circulation research.
[46] T. Jensen,et al. Adeno‐associated virus‐delivered polycistronic microRNA‐clusters for knockdown of vascular endothelial growth factor in vivo , 2012, The journal of gene medicine.
[47] Gianpaolo Zerbini,et al. MiR‐133a regulates collagen 1A1: Potential role of miR‐133a in myocardial fibrosis in angiotensin II‐dependent hypertension , 2012, Journal of cellular physiology.
[48] Yingwang,et al. MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway , 2012 .
[49] Xiaobin Luo,et al. Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated With Experimental Postinfarction Heart Failure , 2012, Circulation. Arrhythmia and electrophysiology.
[50] G. Lip,et al. Atrial fibrillation , 2012, The Lancet.
[51] Li Qian,et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.
[52] Thomas Thum,et al. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart , 2012, AGE.
[53] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[54] M. Goumans,et al. The arterial and cardiac epicardium in development, disease and repair. , 2012, Differentiation; research in biological diversity.
[55] T. Thum,et al. Transforming Growth Factor-&bgr;–Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21 , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[56] R. Hajjar,et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway , 2012, European heart journal.
[57] S. Nattel,et al. MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation , 2013, Circulation.
[58] Da-Zhi Wang,et al. MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress , 2013, Circulation research.
[59] Howard Y. Chang,et al. Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.
[60] M. Giacca,et al. Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure , 2013, Circulation.
[61] M. Hurlé,et al. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. , 2013, International journal of cardiology.
[62] A. Jevnikar,et al. MicroRNA and mRNA Signatures in Ischemia Reperfusion Injury in Heart Transplantation , 2013, PloS one.
[63] J Michael DiMaio,et al. Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.
[64] T. Thum,et al. Detection and transport mechanisms of circulating microRNAs in neurological, cardiac and kidney diseases. , 2013, Current medicinal chemistry.
[65] I. Karakikes,et al. Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling , 2013, Journal of the American Heart Association.
[66] R. Kalluri,et al. miR-21 Promotes Fibrogenic Epithelial-to-Mesenchymal Transition of Epicardial Mesothelial Cells Involving Programmed Cell Death 4 and Sprouty-1 , 2013, PloS one.
[67] B. Maron,et al. Hypertrophic cardiomyopathy , 2013, The Lancet.
[68] Yi Zhang,et al. Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits , 2013, Cell.
[69] A. Didangelos,et al. Extracellular Matrix Secretion by Cardiac Fibroblasts: Role of MicroRNA-29b and MicroRNA-30c , 2013, Circulation research.
[70] H. Hermeking,et al. MicroRNA-34a regulates cardiac ageing and function , 2013, Nature.
[71] Shengshou Hu,et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation , 2013, Journal of Cardiothoracic Surgery.
[72] S. Miyagawa,et al. Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac Surgery , 2013, PloS one.
[73] D. Catalucci,et al. NF‐κB mediated miR‐26a regulation in cardiac fibrosis , 2013, Journal of cellular physiology.
[74] Shinsuke Yuasa,et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors , 2013, Proceedings of the National Academy of Sciences.
[75] R. Shiekhattar,et al. Long Noncoding RNAs Usher In a New Era in the Biology of Enhancers , 2013, Cell.
[76] Shi-long Zhong,et al. Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat , 2013, PloS one.
[77] G. Paolisso,et al. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non‐responders , 2013, European journal of heart failure.
[78] J. D’hooge,et al. Long‐Term miR‐669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice , 2013, Journal of the American Heart Association.
[79] R. Geffers,et al. MicroRNA-Mediated Epigenetic Silencing of Sirtuin1 Contributes to Impaired Angiogenic Responses , 2013, Circulation research.
[80] E. van Rooij,et al. Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model , 2013, Circulation.
[81] T. Thum,et al. Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs. , 2013, Free radical biology & medicine.
[82] V. Regitz-Zagrosek,et al. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. , 2013, International journal of cardiology.
[83] Thomas Thum,et al. Non-coding RNAs in cardiac remodeling and heart failure. , 2013, Circulation research.
[84] P. Couttet,et al. Heart Structure-Specific Transcriptomic Atlas Reveals Conserved microRNA-mRNA Interactions , 2013, PloS one.
[85] G. Ewald,et al. Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support , 2014, Circulation.
[86] D. Brenner,et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.
[87] T. Fernandes,et al. Expression of MicroRNA-29 and Collagen in Cardiac Muscle after Swimming Training in Myocardial-Infarcted Rats , 2014, Cellular Physiology and Biochemistry.
[88] J. Viereck,et al. Regulatory RNAs and paracrine networks in the heart. , 2014, Cardiovascular research.
[89] T. Thum,et al. microRNA therapeutics in cardiovascular disease models. , 2014, Annual review of pharmacology and toxicology.
[90] Douglas Losordo,et al. Exosomes and cardiac repair after myocardial infarction. , 2014, Circulation research.
[91] S. Nattel,et al. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. , 2014, Journal of the American College of Cardiology.
[92] J. Pepper,et al. 178 Circulating Micrornas for Predicting and Monitoring Response to Mechanical Circulatory Support from a left Ventricular Assist Device , 2014, Heart.
[93] P. Puthanveetil,et al. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes , 2014, Journal of cellular and molecular medicine.
[94] Peter Libby,et al. Cardiovascular remodelling in coronary artery disease and heart failure , 2014, The Lancet.
[95] Xiaoke Yin,et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. , 2014, The Journal of clinical investigation.
[96] E. Rooij. MicroRNA therapeutics for cardiovascular disease , 2014 .
[97] M. Mayr,et al. ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models , 2014, European journal of heart failure.
[98] Maria-Teresa Piccoli,et al. Non-coding RNAs in cardiovascular ageing , 2014, Ageing Research Reviews.
[99] G. Lemesle,et al. Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.
[100] T. Tuschl,et al. Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers , 2014, Proceedings of the National Academy of Sciences.
[101] M. Latronico,et al. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[102] T. Engstrøm,et al. Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery , 2014, Scandinavian cardiovascular journal : SCJ.
[103] S. Dimmeler,et al. Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel Growth , 2014, Circulation Research.
[104] F. Liu,et al. The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 , 2014, Circulation research.
[105] B. Schroen,et al. microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation. , 2014, Clinical science.
[106] G. Lemesle,et al. The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .
[107] Hugo A. Katus,et al. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction , 2013, European heart journal.
[108] R. Guigó,et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs , 2014, European heart journal.